Heidi Moore

The safety and efficacy of crisaborole ointment, 2%, was examined in pediatric patients with mild to moderate atopic dermatitis with and without comorbid allergic rhinitis.

Repeated cycles of treatment with crisaborole may be necessary to achieve and maintain control of atopic dermatitis symptoms.

Nearly one-third of patients with cystic fibrosis-related hospitalizations have aspergillosis, which is associated with worse outcomes.